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Abstract
Background: Inappropriate prescription of antibiotics is the leading driver of antimicrobial resistance (AMR). The
majority of antibiotics are prescribed in primary care.
Understanding how general practitioners (GPs) use diagnostic tests and the effect on treatment decision under
daily practice conditions is important to reduce inappropriate prescription of antibiotics. The aim of the study was
to investigate the use of diagnostic tests in primary care patients with suspected urinary tract infection (UTI) and to
assess the appropriateness of the treatment decision (TD) under daily practice conditions in Denmark.
Methods: Prospective observational study. Symptomatic adult patients consulting general practice with suspected
UTI recruited over 12 months. The diagnostic workup was registered in a standardized form. The appropriateness of
the TD was assessed based on the results of a culture performed at a reference microbiological laboratory. TD was
considered appropriate if a patient had a positive culture and was prescribed antibiotics or had a negative culture
and was not prescribed antibiotics. TD was considered inappropriate if a patient had a negative culture and was
prescribed antibiotics (overtreatment) or had a positive culture and was not prescribed antibiotics (undertreatment).
Results: Four hundred and eighty-eight patients were included. Dipstick was used in 98% of the patients and urine
culture was used in 89% of the patients; 317 had the culture performed in practice and 117 had the culture
performed at the hospital. The appropriateness of the final TD was significantly (p = 0.04) lower in patients without
culture (55%) than in patients with culture performed in practice (71%) or at hospital (69%).
Conclusion: In a context with wide availability of diagnostic tests, GPs use diagnostic tests for the decision-making
process in all patients with suspected UTI. Urine culture is used in the majority of the patients and is associated with a
higher proportion of appropriate treatment decisions. Performance of urine culture is therefore important in reducing
inappropriate antibiotic prescribing in patients with suspected UTI seeking care in general practice in Denmark.
Trial registration: ClinicalTrials.gov NCT02249273.
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Background
Optimizing the use of antimicrobials and increasing the
investment in diagnostic tests are part of the key strat-
egies of the World Health Organization (WHO) for
counteracting the spread and development of antimicro-
bial resistance (AMR) [1].
Denmark has a low prescription rate of antimicrobials
at primary health care level in comparison to other
European countries [2]. Nonetheless, there is still a high
use of antibiotics at primary health care level [3].
In Denmark, suspected Urinary tract infection (UTI) is
a frequent cause for antibiotic prescribing [4] and use of
point-of-care tests (POCTs) [5]. There are no national
guidelines on the diagnostic procedures to be followed in
patients with suspected UTI. It is up to the GPs as man-
agers/owners of the practice to decide the type of urine
tests that are available in their practice. Furthermore, it is
up to the GPs as clinicians to decide whether a diagnostic
test should be performed in a patient with suspected UTI.
There is wide availability of diagnostic tests, which can
be used in patients with suspected UTI. The diagnostic
workup may include 1) dipstick, 2) microscopy, 3) cul-
ture performed and interpreted in practice, and/or 4)
culture sent to a hospital laboratory. All practices can
send urine samples for culture at hospital and most
practices have a small laboratory where they can per-
form simple testing. GPs receive a fee for performing
tests in practice, and there is no economic restriction to
the number of tests per individual patient.
The use of urine culture implies a two-step treatment
decision: first a decision when the patient consults the
GP (index consultation), and a second step after the re-
sult of the urine culture is available. For cultures per-
formed in practice, the results can be seen 1 day after
the index consultation, while it may take up to 3 or 4
days to receive the results from a hospital.
In busy primary care, diagnostic test results may not
translate directly to treatment decisions [6, 7], as these
decisions are affected by several contextual factors [8, 9].
Therefore, the impact of diagnostic workup on appropri-
ate treatment should be assessed under daily practice
conditions.
The aim of this study was to describe the use of diag-
nostic tests in patients with suspected UTI and to assess
the impact of the diagnostic work-up on the treatment
decision under daily practice conditions in Denmark.
Methods
Design and setting
The study protocol has been published previously [10].
An observational study of the management of patients
with suspected UTI in general practice under daily prac-
tice conditions was carried out between December 2014
and December 2015. It was part of the context assessment
of a quality improvement program aimed at reducing the
inappropriate prescription of antibiotics in patients with
suspected UTI.
Study population and data collection
A random sample of 500 practices from the capital re-
gion of Copenhagen was invited by letter to participate;
39 accepted the invitation. Each practice included up to
20 patients fulfilling four criteria: a) > 18 years of age, b)
presence of dysuria and/or frequency, c) suspected UTI,
d) not currently taking antibiotics. In a standardized
form the GPs registered number of days with symptoms,
types of symptoms, potential risk factors for UTI, diag-
nostic workup performed, and treatment decision.
Urine sample – Reference standard
All patients were requested to provide a mid-stream
urine sample (approx. 20 ml) of which half could be
used for diagnostic purposes in practice, and the other
half (reference standard) was cultured at a reference la-
boratory (Statens Serum Institute, SSI). The sample ana-
lysed by SSI was preserved in boric acid and sent by
certified post on the day of the consultation. Results
from the reference standard analysis were not available
for the participating GPs.
At SSI, cultures were analyzed by a microbiology techni-
cian who had no information about the clinical history of
the patient. A positive culture was defined as growth of
≥103 colony forming units per milliliter (CFU/ml) for E.
coli and S. saprophyticus, ≥104 CFU/mL for other typical
uropathogens and ≥ 105 CFU/ml for possible uropathogens
according to the European Urinalysis Standards [11].
Definition of variables
As the main focus of analysis was the role of diagnostic
tests in the decision-making process, treatment decision
was selected as the primary outcome [10]. The appropri-
ateness of the treatment decision was evaluated against
the reference standard (i.e. culture at SSI). Treatment de-
cision was considered as appropriate when a patient with
a positive reference culture was prescribed antibiotics or a
patient with a negative culture received no antibiotics.
Treatment decision was considered as inappropriate for
patients with a negative culture who received antibiotics
(overtreatment) or patients with a positive culture who
were not prescribed antibiotics (undertreatment).
UTI was defined as complicated if the patient was a
man, a pregnant woman, a woman ≥65 years, had a rele-
vant co-morbidity or was assessed by the nurse or GP to
have complicated cystitis or pyelonephritis. An anamnes-
tic score was calculated. It is the sum of positive findings
recorded by the GP, in the standardized data collection
form, during the anamnestic phase of the consultation
(range 1–11).
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The diagnostic pathways were categorized into three
groups: a) no urine culture performed, b) urine culture
performed in practice, and c) urine culture performed at
the hospital.
Statistical analysis
The statistical analysis was performed in two steps. First,
possible determinants for the use of the various diagnos-
tic tests were investigated in logistic regression models.
We tested the following predictor variables individually
with practices as a random intercept. The predictors
were: a) anamnestic information, b) availability of diag-
nostic tests and c) information from any diagnostic tests
previously performed (See Additional file 1: Table S1).
Secondly, we used a permutation test to assess the im-
pact of the diagnostic pathway variable on the treatment
decision . The multinomial regression model was adjusted
for the predictors that were significant in the first model
and the differences in baseline characteristics of the diag-
nostic pathway groups. All analyses were performed in the
R programming language and environment v3.3.2 “Sincere
Pumpkin Patch” using the lme4 and nnet package [12].
Ethical aspects
The study was approved by the ethical committee of the
Capital region (case number: H-4- 2014-097). Informed
written consent was obtained from all patients partici-
pating in the study.
Results
Diagnostic workup
Four hundred and eighty-eight patients were recruited
to the study. Dipstick was done in 480 (98%) patients
and microscopy in 160 (32%) patients. 434 (89%) pa-
tients had a urine culture performed as part of the diag-
nostic work-up; done in practices in 317 (65%) and sent
to hospital in 117 (24%) patients. The most common
combination of diagnostic tests was dipstick and culture
done in practice (n = 240, 49% of the patients) – Table 1.
Dipstick results (n = 480) included reactions for nitrite
and leucocytes. In 334 (69%) patients, the two reactions
pointed in different directions: most frequently, the reac-
tion for leucocytes was positive and for nitrite negative.
63 (13%) patients had negative reactions for both nitrite
and leucocytes and 91 (18%) were positive for both.
Microscopy results (n = 160) included identification of
≥ 1 bacteria per High Power Field (HPF) in 106 (66%)
patients; and identification of ≥ 1 white blood cell per
HPF in 70 (43%) patients. Combination of ≥ 1 bacteria
+ ≥ 1 white blood cell per HPF in 30 (19%) patients.
The sensitivity of urine culture performed and inter-
preted in practice was 94% (95% CI 89%; 96%), specificity
51% (95%CI 43%; 59%), Positive Predictive Value – PPV
69% (95% CI 63%; 74%), Negative Predictive Value – NPV
88% (95% CI 79%;93%) – see Additional file 1: Table S2.
The sensitivity of urine culture performed at hospital
was 90% (95% CI 80%; 95%), specificity 89% (95% CI
78%;94%), PPV 90% (95% CI 80%;95%), NPV 89% (95%
CI 78%;94%) – see Additional file 1: Table S3.
Table 2 shows the distribution of baseline characteristics
in patients without culture, those where culture was done
in practices and patients whose culture was sent to hospital.
The proportion of uncomplicated UTIs was higher (70%)
in patients with no culture performed than in patients with
practice culture (60%) or hospital culture (34%).
Identification of predictors for use of additional diagnos-
tic testing is shown in Additional file 1: Table S1. Neither
a suspected complicated UTI nor the results of dipstick or
microscopy predicted the incorporation of urine culture
within the diagnostic workup. The incorporation of a
diagnostic test was predicted by the availability of diagnos-
tic tests. For example, availability of a microscope in prac-
tice decreased the propensity of performing a culture in
practice (OR 0.04, 95% CI 0.004; 0.5) and availability of
culture in practice decreased the propensity of performing
a culture at hospital (OR 0.01, 95% CI 0.001; 0.08).
The incorporation of a diagnostic test was predicted as
well by anamnestic information. For example, a high an-
amnestic score decreased the likelihood of performing
urine culture in practice OR 0.7 (95% CI 0.6; 0.9), but in-
creased cultures at hospital OR 1.5 (95% CI 1.1; 1.9).
Offensive smell increased urine cultures at hospital
OR 2.9 (95% CI 1.2; 7), but not in practice.
Table 1 Distribution of the use of diagnostic tools and
diagnostic pathways
Total (n = 488)
Dipstick 480
Microscopy 160
Culture in practice 317
Culture sent to the hospital 117
Diagnostic pathways
No urine culture (n = 54)
Dipsticks 14
Microscopy 3
Dipsticks + microscopy 37
Urine culture in practice (n = 317)
Dipsticks + urine culture in practice 240
Dipsticks + microscopy + urine culture in practice 76
Urine culture in practice 1
Urine culture sent to the hospital (n = 117)
Dipsticks + urine culture in hospital 73
Microscopy + urine culture in hospital 4
Dipsticks + microscopy + urine culture in hospital 40
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Diagnostic workup and treatment decisions
Table 3 shows the distribution of appropriate treatment
decisions in the three diagnostic pathway groups. The dis-
tribution of the treatment decision was different between
the three diagnostic pathways. For example, the day of the
index consultation (i.e. first treatment decision), overtreat-
ment was seen in 39% of patients without culture, 14% of
those with culture in practice, and 27% of the patients
with culture sent to hospital (p-value: 0.0001).
For the final treatment decision, an appropriate treat-
ment decision was taken in: 55% of patients without cul-
ture, 71% of those with culture in practice, and 69% of the
patients with cultures sent to hospital (p-value = 0.04).
Discussion
Summary of results
In a practice setting with wide availability of diagnostic
tests, nearly all patients with suspected UTI are examined
Table 2 Patients’ baseline characteristics and diagnostic pathways
No culture (n = 54) Culture performed
in practice (n = 317)
Culture performed at
hospital (n = 117)
Prevalence confirmed UTI 29(54) 170(46) 62(52)
Uncomplicated UTI 38(70) 191(60) 41(34)
Women 51(94) 293(92) 110(94)
Younger patients (<=64 years) 41(76) 218(69) 88(75)
Number of days with symptoms (Median-IQR) 2(1;4) 2(1;5) 2(1;4)
Signs & Symptoms
Dysuria 38(70) 214(67) 88(75)
Frequency 38(70) 211(66) 84(72)
Urgency 24(44) 152(48) 73(62)
Suprapubic pain 17(31) 85(27) 45(38)
Dysuria and frequency 25(46) 149(47) 62(52)
Dysuria and urgency 17(31) 106(33) 57(49)
Dysuria and suprapubic pain 11(20) 57(18) 32(27)
Flank pain 4(7) 53(17) 17(14)
Genital symptoms 4(7) 30(9) 16(13)
Reported Fever 1(2) 27(8) 9(7)
Offensive smell 6(11) 57(18) 26(22)
Macrohematuria 4(7) 31(10) 17(15)
UTI within 4 weeks 0 18(6) 14(12)
Othera 6(11) 27(8) 15(13)
Anamnestic scoreb 2(2;3) 3(2;4) 3(2;4)
Figures are n (%), if not marked otherwise a Signs and symptoms not listed in the questionnaire
bMedian IQR (Interquartile range) of signs, symptoms and anamnesis of previous UTI (Score 1 to 11)
Table 3 Appropriateness of the treatment decision and use of diagnostic tests
First treatment decision (p-value = < 0.0001)a Final treatment decision (p-value = 0.04)b
Appropriate Overtreatment Undertreatment Appropriate Overtreatment Undertreatment
No culturec
(n = 54)
30(55) 21(39) 3(6) 30(55) 21(39) 3(6)
Culture performed in practice (n = 317) 176(56) 46(14) 95(30) 227(71) 76(24) 14(5)
Culture performed at hospital (n = 117) 71(61) 32(27) 14(12) 81(69) 24(21) 12(10)
Appropriate = prescribing antibiotics when reference test is positive and not prescribing antibiotics when reference test is negative
Ovrertreatment = prescribing antibiotics when reference test is negative
Undertreatment = not prescribing antibiotics when reference test is positive
Permutation LR test to assess whether treatment decision at the day of the index consultationa or at the day of the final treatment decisionb differs between
groups: a) no culture, b) culture performed in practice, c) culture performed at hospital. Hierarchical model with practices as a random intercept and adjusted for:
complicated versus uncomplicated UTI, offensive smell, anamnesis score, microscope and culture in practice availability
cWhen not performing culture, first treatment decision is the final treatment decision
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with urine dipstick and for most, urine culture is part of
the diagnostic workup. Neither a suspected complicated
UTI nor the results of dipstick or microscopy predict the
incorporation of urine culture within the diagnostic
workup. Incorporation of urine culture within the
decision-making process is associated with a higher pro-
portion of appropriate treatment decisions.
Strengths and limitations
Although a randomized controlled trial might be consid-
ered the ideal design to assess the effect of diagnostic tests
on treatment decisions, there is no consensus about the
best study design to help understand the link between
combination of diagnostic test, test interpretation and
treatment decision [6, 13, 14]. Since our study aimed at
describing the use of diagnostic tests and the appropriate-
ness of the treatment decision under daily practice condi-
tions, a prospective observational design was a sensible
way of capturing the whole decision-making process from
consultation to final treatment decision [15].
The observational study was carried out as part of the
context assessment of a quality improvement program.
It brings about some advantages and disadvantages.
On one hand, the external validity needs to be consid-
ered with caution. Only 39 practices out of 500 accepted
to participate. Previous studies have shown that GPs that
participate in research or quality improvement activities
tend to prescribe fewer antibiotics and are possibly more
interested in reducing inappropriate prescribing than
their non-participating colleagues [16, 17]. Therefore,
the differences shown in this study may be conservative.
On the other hand, observation bias was minimized by
the fact that GPs were interested in obtaining an accur-
ate recording of their decisions under daily practice con-
ditions. This type of medical audit has been extensively
used in Denmark for more than 25 years [18]. The
cornerstone of the methodology is the bottom-up ap-
proach in which the GPs set their own improvement
goals. Hence, there is no point to record data that do
not reflect their everyday practice.
Finally, we cannot completely rule out residual confound-
ing due to unmeasured variables. Nonetheless, the effect of
clustering was considered in the assessment of predictors
and differences between the diagnostic groups. The model
to test the association between the diagnostic pathway
groups and treatment decision was adjusted by the predic-
tors for the combination of tests and differences in baseline
characteristics between the diagnostic pathway groups.
Interpretation of the findings in relation to previous
literature
This study shows the complexity of the decision-making
process in a group perceived as “easy” patients in general
practice [19].
International guidelines recommend the inclusion of urine
culture as part of the diagnostic process only in suspected
complicated UTI to target the right antibiotic choice [20,
21]. In our study, an uncomplicated versus complicated UTI
did not predict the incorporation of urine culture within the
diagnostic workup. It may be explained by the current debate
on finding a new approach [22] to define the type of UTI
based on burden of symptoms, risk factors, and availability
of appropriate antimicrobial therapy. For example, in the no
culture group the median anamnestic score was lower than
in the other two groups. It means GPs possibly considered
these patients as “uncomplicated cases”. Furthermore, the
higher the anamnestic score the higher the probability to
send the urine culture to the hospital and the lower the
probability to perform the urine culture in the practice.
Results from the tests performed previously did not
predict incorporation of a test within the diagnostic
work-up. It indicates a quality problem in the use of
diagnostic tests. An obvious reason for the unsystematic
use of diagnostic tests might be the payment scheme.
Danish primary care system provides economic incentive
for the GP to perform laboratory testing in practice, and
this may have influenced the diagnostic workup.
Nonetheless, shortcomings of the dipstick and micros-
copy may lead to the incorporation of another test in order
to gain certainty on the diagnosis. The use of dipsticks in
primary care needs to take into consideration two import-
ant factors for the interpretation [11]. Firstly, a minimum
bladder incubation time of 4 h, what is difficult if we take
into consideration that one of the main motives of consult-
ation is frequency. Secondly, common uropathogens such
as Enterococcus spp. and Staphylococcus spp. do not re-
duce nitrites. Microscopy requires expertise and the sensi-
tivity is low with colony counts < 105 [23]. Then, Danish
GPs may rely more on the results of a urine culture.
Behavioural and medical reasons may explain the in-
clusion of urine culture in the diagnostic workup for
most patients too.
Sackett et al. have long ago described four diagnostic ap-
proaches in clinical practice [24]. A mixture of the
hypothetico-deductive strategy where the clinician gathers
information to either confirm or refute his/her hypothesis
and the complete history strategy could explain our results.
In a country with a strong antibiotic stewardship program,
GPs are aware of the societal consequences of unnecessary
use of antibiotics. They need to find a way to counteract the
systematic error called “confirmation bias” [25]. This error
arises from the tendency to seek and interpret evidence that
predominantly confirms a pre-existing hypothesis. In our
population, patients entered the study with a suspected UTI,
thus for the GPs it may be difficult to withhold antibiotic
prescribing. Not surprisingly, inappropriate use of antibiotics
is mainly driven by overprescribing of antibiotics and only to
a lesser extent by underprescribing.
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Cardinal symptoms such as dysuria, frequency and ur-
gency has a high negative predictive value [26]. It means,
they are useful to rule out a UTI when absent. However,
in our study population, one of the inclusion criteria was
dysuria and/or frequency so the negative predictive value
could not be used to rule out a UTI.
Urine culture performed in a laboratory is currently
regarded as the best available test to rule in or out an in-
fection [23]. Thus, GPs may see the use of urine culture
as the best way to counteract “the confirmation bias”.
The clinical history plays a role when GPs decide whether
to perform a urine culture in the practice or send it to the
hospital. This has an effect as well on treatment decision.
In patients whose urine culture was performed in
practice, the expectation of obtaining a result the follow-
ing day combined with low anamnestic scores encour-
aged both GPs and patients to withhold antibiotics. The
day of the index consultation, only 14% of patients were
over-treated. However, incorrect interpretation of the
culture resulted in 24% overtreatment for the final treat-
ment decision.
For patients with hospital culture, a few days’ delay of
culture result combined with a higher symptom score
led to more antibiotic overprescribing at the day of the
index consultation (27%). It is in line with a qualitative
study on TDs in patients with suspected UTI, where
GPs preferred to treat empirically due to the discomfort
experienced by the patient [19].
Perspectives
Implementation of effective interventions to reduce in-
appropriate use of antibiotics requires thorough knowledge
of the context in which the decision to prescribe antibiotics
is taken [27]. For example, for the group of GPs that partic-
ipated in this study, education on interpretation of urine
culture in practice or improving communication with the
microbiology department are interventions that might re-
duce the inappropriate prescribing of antibiotics.
This assessment should encourage the implementation
of studies to assess the use of the available diagnostic
tests to set-up improvement strategies that can reduce
the unnecessary prescription of antibiotics within each
context/country.
Finally, the results presented in this paper focus on the
impact on treatment decision. Further research assessing
the cost-effectiveness and impact on patients’ outcomes
should contribute with information to evaluate the
multi-dimensional value of these diagnostic strategies.
Conclusion
In a context with wide availability of diagnostic tests,
GPs use diagnostic tests in all the patients with sus-
pected UTI. It may be explained by economic as well as
medical/behavioural reasons. Inclusion of urine culture
as part of the diagnostic workup leads to appropriate
treatment decision in the majority of the patients.
Performance of urine culture is important for reducing
inappropriate prescribing in patients with suspected UTI
seeking care in general practice in Denmark.
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